India · Delayed Price · Currency is INR Dr. Lal PathLabs Statistics
Total Valuation
NSE:LALPATHLAB has a market cap or net worth of INR 318.28 billion. The enterprise value is 307.30 billion.
| Market Cap | 318.28B |
| Enterprise Value | 307.30B |
Important Dates
The last earnings date was Friday, July 24, 2026.
| Earnings Date | Jul 24, 2026 |
| Ex-Dividend Date | Jul 30, 2026 |
Share Statistics
NSE:LALPATHLAB has 167.06 million shares outstanding. The number of shares has increased by 0.20% in one year.
| Current Share Class | 167.06M |
| Shares Outstanding | 167.06M |
| Shares Change (YoY) | +0.20% |
| Shares Change (QoQ) | +0.04% |
| Owned by Insiders (%) | 54.43% |
| Owned by Institutions (%) | 33.82% |
| Float | 75.68M |
Valuation Ratios
The trailing PE ratio is 58.80 and the forward PE ratio is 48.21. NSE:LALPATHLAB's PEG ratio is 3.09.
| PE Ratio | 58.80 |
| Forward PE | 48.21 |
| PS Ratio | 11.01 |
| PB Ratio | 12.52 |
| P/TBV Ratio | 18.01 |
| P/FCF Ratio | 67.92 |
| P/OCF Ratio | 50.08 |
| PEG Ratio | 3.09 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 37.03, with an EV/FCF ratio of 65.58.
| EV / Earnings | 56.71 |
| EV / Sales | 10.63 |
| EV / EBITDA | 37.03 |
| EV / EBIT | 45.79 |
| EV / FCF | 65.58 |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.08 |
| Debt / EBITDA | 0.24 |
| Debt / FCF | 0.42 |
| Interest Coverage | 27.51 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 36.29% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 5.30% |
| Revenue Per Employee | 5.55M |
| Profits Per Employee | 1.04M |
| Employee Count | 5,206 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, NSE:LALPATHLAB has paid 1.70 billion in taxes.
| Income Tax | 1.70B |
| Effective Tax Rate | 23.78% |
Stock Price Statistics
The stock price has increased by +22.62% in the last 52 weeks. The beta is 0.19, so NSE:LALPATHLAB's price volatility has been lower than the market average.
| Beta (5Y) | 0.19 |
| 52-Week Price Change | +22.62% |
| 50-Day Moving Average | 1,668.11 |
| 200-Day Moving Average | 1,513.83 |
| Relative Strength Index (RSI) | 74.17 |
| Average Volume (20 Days) | 498,416 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:LALPATHLAB had revenue of INR 28.91 billion and earned 5.42 billion in profits. Earnings per share was 32.40.
| Revenue | 28.91B |
| Gross Profit | 17.40B |
| Operating Income | 6.71B |
| Pretax Income | 7.17B |
| Net Income | 5.42B |
| EBITDA | 7.90B |
| EBIT | 6.71B |
| Earnings Per Share (EPS) | 32.40 |
Balance Sheet
The company has 13.31 billion in cash and 1.99 billion in debt, with a net cash position of 11.32 billion or 67.75 per share.
| Cash & Cash Equivalents | 13.31B |
| Total Debt | 1.99B |
| Net Cash | 11.32B |
| Net Cash Per Share | 67.75 |
| Equity (Book Value) | 25.41B |
| Book Value Per Share | 150.21 |
| Working Capital | n/a |
Cash Flow
In the last 12 months, operating cash flow was 6.36 billion and capital expenditures -1.67 billion, giving a free cash flow of 4.69 billion.
| Operating Cash Flow | 6.36B |
| Capital Expenditures | -1.67B |
| Depreciation & Amortization | 1.19B |
| Net Borrowing | -367.55M |
| Free Cash Flow | 4.69B |
| FCF Per Share | 28.05 |
Margins
Gross margin is 60.20%, with operating and profit margins of 23.22% and 18.74%.
| Gross Margin | 60.20% |
| Operating Margin | 23.22% |
| Pretax Margin | 24.79% |
| Profit Margin | 18.74% |
| EBITDA Margin | 27.33% |
| EBIT Margin | 23.22% |
| FCF Margin | 16.96% |
Dividends & Yields
This stock pays an annual dividend of 20.00, which amounts to a dividend yield of 1.05%.
| Dividend Per Share | 20.00 |
| Dividend Yield | 1.05% |
| Dividend Growth (YoY) | 33.33% |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.20% |
| Shareholder Yield | 0.85% |
| Earnings Yield | 1.70% |
| FCF Yield | 1.47% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for NSE:LALPATHLAB is 1,920.15, which is 1.06% higher than the current price. The consensus rating is "Buy".
| Price Target | 1,920.15 |
| Price Target Difference | 1.06% |
| Analyst Consensus | Buy |
| Analyst Count | 26 |
| Revenue Growth Forecast (3Y) | 13.90% |
| EPS Growth Forecast (3Y) | 18.05% |
Stock Splits
The last stock split was on December 19, 2025. It was a forward split with a ratio of 2.
| Last Split Date | Dec 19, 2025 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |